Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
CASI similar filings
- 21 Mar 23 Registration of securities for employees (post-effective amendment)
- 21 Mar 23 Registration of securities for employees (post-effective amendment)
- 13 Aug 21 Registration of securities for employees (post-effective amendment)
- 13 Aug 21 Registration of securities for employees (post-effective amendment)
- 13 Aug 21 Registration of securities for employees (post-effective amendment)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
CASI Pharmaceuticals, Inc.:
We consent to the use of our report dated March 30, 2021, with respect to the consolidated financial statements of CASI Pharmaceuticals, Inc., incorporated herein by reference.
/s/ KPMG Huazhen LLP
Beijing, China
August 13, 2021